The merger further expands PharmaLex’s Nordic presence, providing greater capacities and capabilities in regulatory affairs and pharmacovigilance
Friedrichsdorf (Ts.) / Mannheim / Copenhagen, July 14th, 2016: As of July 5th, 2016, the PharmaLex Group, a leading specialist provider of Development Consulting & Scientific Affairs, Regulatory Affairs and Pharmacovigilance, has completed the formal merger with Jacobsen Advice (Denmark).
Jacobsen Advice was founded in 1995 by Anette Jacobsen and has grown from a ‘onewoman band’ to a successful regulatory affairs consultancy, employing 19 people across two offices in Sønderborg and Hørsholm in Denmark. Their expertise covers mainly regulatory affairs and pharmacovigilance across the entire product lifecycle – pre- and post-launch.
“Our key focus is to provide our clients with the benefits that a greater international reach provides” explained Anette Jacobsen, CEO, Jacobsen Advice. “It is an important step for us to join the PharmaLex Group and we are all very much looking forward to this next phase in our development”, she added. “We are delighted to welcome Jacobsen Advice to the PharmaLex family. This addition of regulatory affairs expertise compliments and provides
even greater strength to our existing services in the Nordic region” explained Dr. Thomas Dobmeyer, CEO PharmaLex. “Our continued growth is a commitment both to our clients and our industry. We believe that having a greater global reach has significant benefits for our clients, whilst strengthening our competitive advantage. With Jacobsen Advice on board, we are able to provide an enhanced service portfolio to the Nordic region” added Dr. Tilo Netzer, CEO PharmaLex.
For further information, please contact:
Ms. Eva Keck
PharmaLex GmbH; Director Business Development Operations
+49 621 18 15 38 0
Harrlachweg 6; 68163 Mannheim